Table 2.
The Clinical Characteristics of Participants (N = 216)
| Characteristics | Categories | Total (N = 216) | CAM user (n = 131) | CAM nonuser (n = 85) | χ2/t | p |
|---|---|---|---|---|---|---|
| Cancer type | Head and neck | 26 (12.0) | 14 (10.7) | 12 (14.1) | 3.70 | 0.72 |
| Lung | 20 (9.3) | 9 (6.9) | 11 (12.9) | |||
| Breast | 36 (16.7) | 24 (18.3) | 12 (14.1) | |||
| Gastrointestinal | 52 (24.1) | 31 (23.7) | 21 (24.7) | |||
| Genitourinary | 12 (5.6) | 8 (6.1) | 4 (4.8) | |||
| Gynecologic | 67 (31.0) | 43 (32.8) | 24 (28.2) | |||
| Others | 3 (1.3) | 2 (1.5) | 1 (1.2) | |||
| Time duration | <6 | 34 (15.7) | 16 (12.2) | 18 (21.1) | 3.31 | 0.19 |
| since diagnosis/mo | 6–12 | 30 (13.9) | 20 (15.3) | 10 (11.8) | ||
| >12 | 152 (70.4) | 95 (72.5) | 57 (67.6) | |||
| Cancer stage | T1 | 63 (29.2) | 37 (28.3) | 26 (30.6) | 14.02 | 0.003 |
| T2 | 26 (12.0) | 11 (8.4) | 15 (17.6) | |||
| T3 | 57 (26.4) | 29 (22.1) | 28 (33.0) | |||
| T4 | 70 (32.4) | 54 (41.2) | 16 (18.8) | |||
| Distant | M0 | 148 (68.5) | 79 (60.3) | 69 (81.2) | 10.41 | 0.001 |
| metastasis | M1 | 68 (31.5) | 52 (39.7) | 16 (18.8) | ||
| Treatment | Surgerya | 51 (23.6) | 27 (20.6) | 24 (28.2) | 6.28 | 0.18 |
| Chemotherapy | 89 (41.2) | 50 (38.2) | 39 (45.9) | |||
| Radiotherapy | 4 (1.9) | 2 (1.5) | 2 (2.4) | |||
| CRRT | 11 (5.1) | 8 (6.1) | 3 (3.5) | |||
| Post-treatmentb | 61 (28.2) | 44 (33.6) | 17 (20.0) |
Italic bold values are significant.
Unless otherwise noted, values are the number (percentage) of patients.
a
Postoperative follow-up.
b
Postcancer treatment checkup.
CRRT, concurrent chemoradiotherapy.